• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE; IMPLANTABLE LEAD Back to Search Results
Model Number 0273
Device Problems Failure to Capture (1081); Over-Sensing (1438); Pacing Problem (1439); Under-Sensing (1661); Device Dislodged or Dislocated (2923)
Patient Problem Twiddlers Syndrome (4563)
Event Date 09/13/2023
Event Type  Injury  
Event Description
It was reported that this implantable cardioverter defibrillator (icd) exhibited oversensing of atrial signals leading to double counting of the rate and resulting in a single burst of anti-tachycardia pacing (atp) given.Boston scientific technical services (ts) was consulted and further evaluation was recommended to determine the right ventricular (rv) lead position.Additional information was received that undersensing and loss of capture (loc) were also observed.A chest x ray confirmed a lead dislodgement and was suspected to be due to twiddler syndrome.A revision procedure was performed and this lead was explanted and replaced.No additional adverse patient effects were reported.
 
Manufacturer Narrative
This lead was thoroughly inspected and analyzed upon receipt at our quality assurance laboratory.Damage to the lead was noted.Due to the location and morphology of damage to the lead it is likely that external stress applied to the lead body resulted in the clinical observations.Past experience suggests patient manipulation of the lead through the skin (i.E., twiddler's syndrome) is a contributing factor to damage of this type.
 
Event Description
It was reported that this implantable cardioverter defibrillator (icd) exhibited oversensing of atrial signals leading to double counting of the rate and resulting in a single burst of anti-tachycardia pacing (atp) given.Boston scientific technical services (ts) was consulted and further evaluation was recommended to determine the right ventricular (rv) lead position.Additional information was received that undersensing and loss of capture (loc) were also observed.A chest x ray confirmed a lead dislodgement and was suspected to be due to twiddler syndrome.A revision procedure was performed and this lead was explanted and replaced.No additional adverse patient effects were reported.This lead has been received for analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOTAK RELIANCE
Type of Device
IMPLANTABLE LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key17830886
MDR Text Key324431290
Report Number2124215-2023-53221
Device Sequence Number1
Product Code NVY
UDI-Device Identifier00802526601811
UDI-Public00802526601811
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P910073/S077
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 10/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model Number0273
Device Catalogue Number0273
Device Lot Number123202
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/25/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/18/2023
Initial Date FDA Received09/28/2023
Supplement Dates Manufacturer Received10/27/2023
Supplement Dates FDA Received10/30/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/23/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age58 YR
Patient SexFemale
-
-